Skip to content

Phathom Pharmaceuticals, Inc.

PHAT· NasdaqCore metricsCIK 1783183

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.56%
Market cap
$506.85M
81.29M shares
Filings
496
$84.72M
Q3 2026+216.9% FY25 yoy
-$13.90M
Q3 2026N/M FY25 yoy
-$85.00K
Q3 2026N/M FY25 yoy
-$15.95M
Q3 2026derivedN/M FY25 yoy
-$0.16
Q3 2026N/M FY25 yoy
$184.56M
Q3 2026−56.3% FY25 yoy
$506.85M
—
1.8×
—
-4.15%
—

Twelve months to Sep 30, 2026 · derived

Price

$6.2456.58%$8.13past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$175.11MFY 2025
$175.11M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$175,110,000reported
FY 20242024-12-31$55,252,000reported
FY 20232023-12-31$682,000reported
FY 20222022-12-31$0reported

Pharmaceutical preparations

Phathom Pharmaceuticals, Inc. is the 91st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR